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Blepharospasm (BSP) is a rather distressing form of focal dystonia. Although many 
aspects of its pathophysiological mechanisms are already known, we lack fundamental 
evidence on etiology, prevention, and treatment. To advance in our knowledge, we need 
to review what is already known in various aspects of the disorder and use these bases 
to find future lines of interest. Some of the signs observed in BSP are cause, while 
others are consequence of the disorder. Non-motor symptoms and signs may be a 
cue for understanding better the disease. Various cerebral sites have been shown to be 
functionally abnormal in BSP, including the basal ganglia, the cortex, and the cerebellum. 
However, we still do not know if the dysfunction or structural change affecting these 
brain regions is cause or consequence of BSP. Further advances in neurophysiology 
and neuroimaging may eventually clarify the pathophysiological mechanisms implicated. 
In this manuscript, we aim to update what is known regarding epidemiology, clinical 
aspects, and pathophysiology of the disorder and speculate on the directions of research 
worth pursuing in the near future.
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iNTRODUCTiON
Blepharospasm (BSP) is a form of focal dystonia that manifests with spasms of the eyelids, involun-
tary closure of the eye, and enhanced spontaneous blinking, or any combination of the previous ones. 
We have advanced in our knowledge of the disorders since the first descriptions of BSP as a form of 
dystonia (1, 2). However, there are still many unknown aspects in the generation of the disorder and 
unclear points in the pathophysiological mechanisms of the various forms of focal dystonia. BSP is 
particularly distressing. Patients may be functionally blind and unable to pursue a normal social life, 
with plenty of emotional and behavioral consequences. In this manuscript, we aim to update what is 
known regarding epidemiology, clinical aspects, and pathophysiology of the disorder and speculate 
on the directions of research worth pursuing in the near future.
Review OF KNOwN BSP PHeNOMeNOLOGY
epidemiology, Clinical Aspects, and Diagnostic Tools
Although BSP is now recognized as one of the most common forms of adult-onset dystonia, it 
is thought to be rare, affecting about 16–133 cases per million (3). By most studies, BSP seems 
to be less prevalent than primary cervical dystonia (CD) but in Japan, and in Italy too, the trend 
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is reversed, BSP being more frequent than CD (3). Peculiar 
characteristics of the BSP are female preference (3), peak age 
at onset between the fifth and the seventh decade, and a greater 
tendency to spread to adjacent body parts (usually within the 
first 5 years of history) than cervical and upper limb dystonia 
(4). BSP patients may also have tremor in the head or upper 
limbs (5).
Motor Phenomenology
Blepharospasm is characterized by stereotyped, bilateral, and 
synchronous spasms of the orbicularis oculi muscles. Spasms 
may be brief or sustained and may induce narrowing or closure 
of the eyelids. Other relevant manifestations include: sensory 
trick that can transiently improve eyelid spasms in about half 
of the patients (6), associated apraxia of eyelid opening (7), and 
increased spontaneous blink rate (8). Whether increased blinking 
may preceed BSP is an open question for future studies (9).
A diagnostic algorithm has been developed, based on motor 
manifestations of stereotyped, bilateral, and synchronous orbicu-
laris oculi spasms, identification of sensory trick or, alternatively, 
increased blinking (5, 10, 11), which yielded 93% sensitivity and 
90% specificity in distinguishing BSP from other conditions of 
involuntary lid closure such as eyelid tics, hemifacial spasms, 
facial chorea, apraxia of eyelid opening, frequent blinking, and lid 
ptosis due to myasthenia or other causes. The new severity scale 
was based on six clinical aspects, including degree and duration 
of eyelid closure, frequency of spasms, presence of apraxia of eye-
lid opening, occurrence of spasms during writing and increased 
blinking. The scale is suitable to assess BSP severity in clinical 
practice and research, yielding moderate to almost perfect reli-
ability and acceptable clinimetric properties (5, 11).
Non-Motor Phenomenology
Several non-motor manifestations may be more frequent in 
BSP patients than in healthy or disease controls. They belong to 
four domains: sensory symptoms, psychiatric disorders, sleep 
disorders, and cognitive disturbances. Symptoms belonging to 
the sensory domain include burning sensation and grittiness in 
the eye, dry eye, and photophobia. Theoretically, eye symptoms 
may be part of the spectrum of BSP but they can also result from 
eye diseases of the anterior segment of the eyes, which have 
been identified with 77% sensitivity and 94% specificity in BSP 
patients (12).
Psychiatric alterations include depression, anxiety, and obses-
sive–compulsive disorders (13, 14). The finding is not specific 
because psychiatric disturbances, mostly depression, are also 
more frequent in patients with various forms of focal dystonia 
than in healthy controls. Theoretically, psychiatric disorders may 
be part of the clinical spectrum of the disease or secondary to the 
dystonia-induced disability. By most studies, depression appears 
to represent a feature of primary dystonia, whereas other psy-
chiatric abnormalities have a less certain relationship and need 
additional evaluation.
Sleep impairment may be another feature of BSP (15). It seems 
to be independent of motor severity but rather correlated with 
depression. Therefore, it is not clear at present if there is a primary 
sleep abnormality in dystonia. Further studies are warranted.
There is little evidence of alteration of cognitive functions in 
idiopathic dystonia. Nevertheless, a recent study showed that 
non-depressed and non-demented patients with cranio-CD and 
normal IQ may have impairments in several specific cognitive 
domains including working memory, information processing 
speed, and set-shifting capacity (16). Altered cognitive measures 
were independent of the clinical expression of dystonia.
Neuroimaging
Structural
As in other forms of focal dystonia, BSP is considered to originate 
from a dysfunction in basal ganglia circuitry, although other brain 
and brainstem circuits can also be involved. Lesions causing BSP 
have been identified in various sites. In the analysis of their own 
cases, Khooshnoodi et al. (17) found 18 out of 1114 patients with 
BSP to have brain lesions that could account for their symptoms 
(1.6%). In a total of 48 cases (30 of them extracted from the 
literature), these authors reported lesions in several parts of the 
brain, including the thalamus in 12, lower brainstem in 11, basal 
ganglia in 9, cerebellum in 9, midbrain in 7, and cortex in 1. These 
observations have contributed to the idea of a widely distributed 
network of regions where lesions can potentially lead to BSP.
Although evidence for lesions in patients with BSP is scarce, 
researchers on brain neuroimaging have found group abnor-
malities in various sites also. The first to report on volumetric 
abnormalities in idiopathic focal dystonia was Black et al. (18). 
These authors studied 13 patients (5 with BSP and 8 with hand 
dystonia) and found that the gray-matter volume (GMV) of 
the putamen was about 10% larger in patients than in healthy 
controls. The authors speculated on the possibility that putaminal 
GMV change could be a response to dystonia if not related to its 
cause. A putaminal increase in GMV was confirmed in 16 patients 
with BSP by Etgen et al. (19) who used voxel-based morphometry 
rather than a direct analysis of a region of interest. These authors 
observed also decreased GMV in the left inferior parietal lobe, 
which correlated significantly with duration of botulinum toxin 
treatment and suggested a crucial role for the putamen in the 
pathophysiology of focal dystonia and secondary changes related 
with the tonic spasms and their botulinum toxin treatment for 
the left parietal region.
However, not all studies confirmed the increase in volume 
and hyperactivity in the striatal region. Obermann et  al. (20) 
found a decrease rather than an increase in GMV in the puta-
men and thalamus bilaterally, whereas they reported increased 
GMV in the caudate head and the cerebellum, also bilaterally. In 
this study, though the authors examined patients with BSP (11) 
together with patients with CD (9) in an attempt to find common 
sites of involvement shared by these two forms of focal dystonia. 
In any case, they concluded that the morphometric changes 
found were located within structures important for sensorimotor 
integration and motor control, pointing out to a functional dam-
age that, with time, may lead to structural changes. Other authors 
reported no significant change in microstructure of basal ganglia 
using diffusion tensor imaging (7) or voxel-based morphometry 
(21). The latter study is relevant for reporting, apart from the 
absence of changes in the basal ganglia, greater GMV in BSP 
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patients than in healthy volunteers in the right middle frontal 
gyrus and the reverse pattern (i.e., smaller GMV in patients 
than in healthy volunteers) in the left postcentral gyrus and left 
superior temporal gyrus. Therefore, these authors concluded 
that patients may have cortical but no basal ganglia changes. It 
is difficult to know the cause of the differences in the findings 
reported by Martino et al. (21) and those reported by Etgen et al. 
(19). Martino et al. (21) argued that the number of patients they 
studied was larger: 25 vs. 16 studied by Etgen et al. (19). However, 
it is difficult to believe that nine patients can account for the dif-
ferences reported. Other factors have to be taken into account 
to explain the different findings reported so far, such as age at 
disease onset, disease duration, presence of dystonia spread to 
other body sites, dystonia severity, and duration and mean dose 
of botulinum toxin treatment. In none of these variables, the 
authors found a correlation with the neuroimaging findings but 
there can still be some influence from these variables enough 
to tilt the subtle abnormalities of BSP patients toward one or 
another direction.
Involvement of the cortex and the corticonuclear tract was 
supported by another morphometric study (22) that showed a sig-
nificant decrease in GMV in the facial portion of the left primary 
motor cortex and right anterior cingulate of BSP patients when 
compared to healthy volunteers. An interesting comparison was 
made by Ramdhani et al. (23) between patients with task-specific 
(laryngeal dystonia and writer’s cramp) and non-task specific 
(BSP and CD) forms of dystonia. They found that GMV changes 
in task-specific dystonia involved the brain regions responsible 
for sensorimotor control during writing and speaking, such as 
primary somatosensory cortex, middle frontal gyrus, superior/
inferior temporal gyrus, middle/posterior cingulate cortex, and 
occipital cortex as well as the striatum and cerebellum (lobules 
VI–VIIa), whereas those in non-task-specific dystonia were 
limited to the left cerebellum (lobule VIIa) only. The authors 
concluded that these two forms of dystonia may have different 
pathophysiological mechanisms, may be precipitated by different 
triggers and express in neuroimaging as distinct microstructural 
patterns. The findings of Ramdhani et al. (23) are indeed stimu-
lating for going further on structural and functional analysis of 
the brain in different forms of dystonia. They also put on show 
the contribution of the cerebellum as a key structure in the brain 
dystonia network (22, 24).
Indeed, the latest findings in neuroimaging studies have 
revealed microstructural abnormalities in the cerebellum. Yang 
et  al. (25) studied diffusion tensor imaging and voxel-based 
fractal anisotropy in 9 patients with BSP alone, compared with 
11 patients with BSP plus oromandibular dystonia. BSP patients 
showed significant FA reductions in the left anterior lobe of 
cerebellum that correlated negatively with disease severity, 
while patients with BSP and oromandibular dystonia showed an 
increase of FA in the right parietal lobe that correlated negatively 
with disease duration. Other abnormalities were also found in 
areas around the right precuneus, lentiform nucleus, and insula 
in different combinations in the two groups of patients. The 
authors concluded that white-matter changes outside the basal 
ganglia may present trait features that are specific for individual 
phenotypes of dystonia.
Functional
Many functional abnormalities have been reported in BSP 
patients. In 1995, Smith et al. (26) used [18F]fluorodeoxyglucose 
positron emission tomography (18-FDG PET) to find abnormally 
reduced medial frontal lobe glucose metabolism in four patients 
with apraxia of lid opening. A similar study on 10 patients with 
BSP showed increased glucose metabolism in the striatum and 
thalamus (27). Two interesting additional observations were 
made in that study: five patients were investigated before and after 
treatment of muscle spasms with botulinum toxin and showed 
similar results, indicating that the abnormalities were intrinsic of 
the disorder and not the consequence of increased muscle activ-
ity. On the other side, the authors did not find any significant 
correlation between severity of the spasms and the degree of 
striatum or thalamus hypermetabolism. Abnormalities in basal 
ganglia and frontal cortex have been reported since then, using 
various functional neuroimaging techniques, in various studies 
of patients with BSP (28). Kerrison et al. (29) reported cortical 
areas of increased glucose metabolism (inferior frontal gyri, right 
posterior cingulate gyrus, left middle occipital gyrus, fusiform 
gyrus of the right temporal lobe, and left anterior cingulate gyrus) 
and others with decreased glucose uptake (a region ventral to the 
area of increased glucose metabolism in the frontal inferior gyri). 
They also found increased glucose uptake in the right caudate 
and decreased glucose uptake in the left inferior cerebellar 
hemisphere and thalamus. Hutchinson et al. (30) examined PET 
in six BSP patients during sleep to avoid the possible confound-
ing effect of spasm-related muscular contractions. They found 
that during sleep, patients showed frontal hypometabolism in 
a region associated with cortical control of eyelid movements 
while they showed hypermetabolism of the cerebellum and pons 
during wakefulness, when they exhibited involuntary muscle 
contractions. Apart from that, network analysis demonstrated 
overactivity of the lentiform nuclei, cerebellum, and the supple-
mentary motor regions, reported by the same authors previously 
to be a pattern of abnormalities associated with other forms of 
dystonia. In a similar line of reasoning, Suzuki et al. (31) used 
also 18-FDG PET to investigate cerebral glucose metabolism in 
BSP patients whose spasms were suppressed by botulinum toxin 
injections. They found significant increase in glucose metabolism 
in the thalamus and pons that they interpreted as an expression 
of a compensatory change, common to pathophysiological 
mechanisms in other types of focal dystonia. The same authors 
have recently reported that the increase in putaminal glucose 
metabolism shown using 18-FDG PET in patients with essential 
BSP may separate them from those with drug-induced BSP who 
did not show such increase. A correlation between severity of the 
spasm and the intensity of increased glucose metabolism in the 
thalamus was reported by Murai et al. (32) in a study of a single 
patient who underwent five PET sessions during a follow-up of 
22 months. An interesting approach was taken by Emoto et al. 
(33), who used 18-FDG PET to characterize photophobia in BSP 
patients. These authors found that patients with photophobia had 
significant hypermetabolism in the thalamus, while those without 
photophobia had significant hypometabolism in the superior col-
liculus. These findings may underlie mechanisms for the increase 
in the blinking rate in BSP patients with photophobia.
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A functional magnetic resonance imaging (fMRI) study with 
analysis of the blood oxygenation level-dependent signal was 
done during spasms by Schmidt et al. (34). Healthy volunteers 
were asked to make a voluntary closing of their eyelids that 
was to be contrasted with rest, while patients were requested to 
press a button to mark the onset of their spasms. The authors 
reported on various areas activated with blinking, common 
to patients and healthy subjects, such as frontal and parietal 
operculum, supplementary motor area, primary sensorimotor 
cortex, various visual areas, and the cerebellum. The site where 
differences were observed was a subregion of the putamen, where 
the authors found hyperactivation in patients in comparison to 
healthy volunteers. Baker et al. (35) reported on the fMRI study 
of spontaneous and voluntary blinking in five BSP patients 
and five healthy subjects. The authors found greater activation 
in BSP patients than in control subjects in the anterior visual 
cortex, anterior cingulate cortex, primary motor cortex, central 
region of the thalamus, and superior cerebellum. Therefore, their 
findings suggested the existence of a hyperactive cortical circuit 
linking visual cortex, limbic system, supplementary motor cortex, 
cerebellum, and supranuclear motor pathways innervating the 
periorbital muscles. The existence of an abnormal default mode 
network implying the cortico-striato-pallido-thalamic loop has 
been suggested by Zhou et al. (36) after a fMRI study of resting 
state and voxel-based analysis of amplitude of low-frequency 
fluctuations.
Dopamine binding has been also examined in BSP. The first 
report was made in 1997 by Perlmutter et al. (37) who used PET 
to measure binding of radioligand [18F]spiperone in putamen in 
21 patients and 13 healthy subjects to find decreased dopamine 
D2-like binding in 29% in dystonic patients. This was confirmed 
by Horie et al. (38), who found decreased binding in the entire 
striatal region (by a similar percentage in caudate and anterior 
and posterior putamen). The authors speculated on the pos-
sible mechanism relating dopamine ligand striatal deficit and 
decreased inhibition in BSP, typical of all forms of dystonia.
Neurophysiology
Dystonia is a functional disorder, and therefore, neurophysiol-
ogy is a key methodology for its study, both for recognizing the 
underlying pathophysiological mechanisms and providing cues 
for the differential diagnosis when clinical signs and symptoms 
are not sufficiently clear. In the case of BSP, the most useful 
neurophysiological test is the blink reflex, which can be used to 
examine the excitability of brainstem interneurons, modulated in 
turn by circuits feeding on basal ganglia output signals (39–41).
Electromyography
The paradigmatic feature of dystonia is cocontraction between 
antagonistic muscles in attempts to perform a discrete move-
ment. Therefore, one of the key methods for the documentation 
of abnormalities requires electromyographic recording of antago-
nistic muscles. This is not feasible in the muscles controlling the 
eyelid, the levator palpebrae, being unavailable to non-invasive 
electromyography recordings. A few authors have recorded 
from the levator palpebrae with needle electrodes showing the 
expected reduction of reciprocal inhibition (42, 43).
Simple observation of spontaneous blinking allows deter-
mining the rate of spontaneous blinking and the strength and 
duration of eye closure, measures that are rather useful for the 
characterization of BSP. Additional information can be obtained 
by recording the EMG activity from the orbicularis oculi with a 
pair of electrodes attached over the skin overlying the muscle at 
the lower eyelid. In healthy subjects, spontaneous blinking results 
from a brief phasic activation of the orbicularis oculi and relaxa-
tion of the levator palpebrae, but in BSP patients, the amount 
of EMG activity in the orbicularis oculi is usually markedly 
increased (41, 44, 45).
Blink Reflex
The study of reflex blinking is an important aspect of the evalu-
ation of patients with neurological disorders. In the clinical con-
text, gentle tapping of the forehead is the most common method 
to induce reflex blinking. If done repeatedly, clinicians are able 
to assess the inhibitory control of the reflex (the Myerson’s 
maneuver). A startling stimulus, whether auditory, visual, or 
somatosensory, elicits reflex blinking as a form of eye protec-
tion (41, 46). However, the method that has been mostly used 
for the assessment of reflex blinking is the electrical activation 
of the supraorbital nerve while recording the EMG responses of 
the orbicularis oculi (47), which is conventionally known as the 
blink reflex. The electrically induced trigemino-facial blink reflex 
consists of two separate components: an early ipsilateral R1 and a 
late bilateral R2. R1 is a pontine reflex, while R2 is relayed through 
a more complex route including the pons and lateral medulla. The 
fact that unilateral stimuli give rise to bilateral responses permits 
separate assessment of the afferent and the efferent arms of the 
reflex circuit. Additionally, the blink reflex can be used to exam-
ine various functions that are either integrated in, or mediated 
by, the brainstem. If no peripheral nerve lesions interfere with the 
recording, the study of blink reflex becomes a useful technique 
for the assessment of supranuclear control of brainstem interneu-
ronal excitability (41).
The best-known method for the assessment of blink reflex 
excitability is the paired shock technique, which consists in apply-
ing pairs of supraorbital nerve stimuli of the same intensity (48). 
The first stimulus (conditioning) induces a transient change in the 
excitability of reflex circuits, and the second stimulus (test), deliv-
ered at varying inter-stimulus intervals with respect to the first, is 
used as the probe stimulus. The size of the response elicited by the 
test stimulus is expressed as a percentage of the response to the 
conditioning stimulus, and a X–Y graph of excitability recovery 
can be represented for all intervals tested (usually between 100 
and 1000 ms). The R2 response is usually completely abolished 
from 0 to 200–300 ms, then very slowly recovers, reaching about 
30–50% at the 500 ms interval and 70–90% at the 1500 ms interval 
in healthy volunteers. Blink reflex excitability is assumed to be 
under the control of rostral structures, including the basal ganglia 
(39, 40) and is abnormally enhanced in patients with BSP, which 
shows as a shift to the left in the excitability recovery curve. The 
Figure 1 shows the methods and results in a single case.
Blink reflex excitability enhancement is not specific for dys-
tonia, and, therefore, the test cannot be used for the diagnosis, 
although the data obtained may reinforce clinical suspicion. 
FiGURe 1 | The study of the blink reflex excitability recovery curve in 
blepharospasm. (A) The most frequently used method to examine patients 
with BSP is the recording of blink responses by surface electrodes attached 
over the orbicularis oculi muscles. (B) Partial results from a study of blink 
reflex excitability recovery in a healthy control and a BSP patient. Pair of 
supraorbital nerve stimuli are applied either 100 or 200 ms apart. The 
conditioning stimulus (C) elicits the typical blink reflex, composed by R1 and 
R2 responses. The test stimulus (T) elicits no R2 response in the healthy 
control, which reflects the normal lack of excitability at such short intervals, 
whereas they elicit an R2 response in the patient, larger with the interval of 
200 ms, reflecting the enhanced blink reflex excitability, characteristic of BSP. 
Part (A) of this figure was previously published as part of Figure 19.6 of Ref. 
(45) and is reproduced with permission from Elsevier. Part (B) of this figure 
was previously published as Figure 1 in Valls-Sole’s “Assessment of 
excitability in brainstem circuits mediating the blink reflex and the startle 
reaction,” published in Ref. (41), and is reproduced with permission from 
Elsevier.
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Interestingly, however, it has been reported normal in patients 
with psychogenic dystonia (49), which makes the test clinically 
very useful. In fact, blink reflex excitability depends on excitatory 
inputs reaching brainstem interneurons in the trigemino-facial 
pathway. One such input is a startling auditory stimulus (SAS). 
This generalized reflex response, and the more discrete auditory 
blink reflex, is mediated by the nuclei of the reticular formation. 
A regulatory step in the pathway is likely the pedunculopontine 
tegmental nucleus, which also receives inputs from the internal 
pallidum and other basal ganglia nuclei. The pedunculopontine 
nucleus has an inhibitory action on the startle blinking, and one 
way to document the inhibitory control of the blink reflex is 
prepulse inhibition (50, 51).
Prepulse inhibition is defined as the inhibitory effect of a 
stimulus (weak enough not to induce a reflex response by its 
own) on the response to another, suprathreshold, stimulus. This 
effect is considered to be due to the attentional shift required to 
process the information brought about by the prepulse. Prepulse 
inhibition has been found abnormal in patients with BSP, particu-
larly in those who cannot find relief of their symptoms using a 
“geste antagonistique” (52). The abnormalities in prepulse inhibi-
tion show functional impairment of a circuit that is different from 
that of the blink reflex excitability recovery curve (53).
An animal model of BSP has been reported in which a 
6-hidroxi-dopamine lesion of the striatum together with a 
peripheral nerve lesion may lead to enhanced reflex gain (54, 55). 
This may apply to humans with some predisposition to develop 
dystonia, where unilateral peripheral facial nerve lesions lead 
to enhancement of blink reflex excitability recovery in the side 
contralateral to paresis. That such changes in the contralateral 
facial nerve are related to the afferent input from the cornea 
of the paralyzed side was first suggested by Chuke et  al. (56), 
who found that the BSP-like sustained contraction of the facial 
muscles of the side contralateral to the paralysis was relieved by 
helping to close the eye with a weight added to the paralyzed 
eyelid. Further evidence in the same direction was reported by 
Manca et  al. (57), who analyzed the size differences between 
the responses recorded in the non-paralyzed side to ipsi- and 
contralateral supraorbital nerve electrical stimulation. These 
are examples of maladaptive plastic changes in the control of 
brainstem excitability that, in predisposed subjects, may lead to 
clinical expression of dystonia.
Other Neurophysiology-Based Recordings
Little information exists on direct neurophysiological record-
ings from the structures supposedly dysfunctional in BSP, i.e., 
the basal ganglia, thalamus, brainstem, or cerebellum. Deep 
brain stimulation (DBS) has been used scarcely to treat BSP 
patients because significant symptomatic alleviation is usually 
provided by injections of botulinum toxin in the orbicularis 
oculi muscles. The few reports published on DBS in BSP patients 
(actually in patients combining BSP and oromandibular dys-
tonia) deal with clinical and epidemiological aspects (58–60). 
Special mention should be given to the report of a single patient 
by Foote et al. (61). In this case, the authors reported an increase 
in single cells firing rates in the GPi of the right side, which may 
relate to the hyperactivity reported with neuroimaging studies. 
An interesting aspect is that the firing rate was less increased in 
the left side, operated 6 months after the right side, indicating 
effect of DBS beyond the site of implantation. DBS may not 
always be beneficial but sometimes may worsen symptoms in 
BSP patients (62).
The blink reflex can be elicited not only by trigeminal stimuli 
but also by other somatosensory stimuli applied elsewhere in the 
body, the so-called somatosensory blink reflex (63). This type of 
reflex has been also reported to show an abnormal excitability 
enhancement in patients with BSP (64), which challenges the 
hypothesis of the influence of the basal ganglia over trigeminal 
neuronal excitability as the cause of the alterations of the blink 
reflex in BSP, unless we assume that the somatosensory inputs 
use common interneurons to the trigemino-facial pathway for 
the elicitation of the blink reflex. An auditory stimulus elicits 
also a blink reflex and this has been found exaggerated in BSP 
patients (65). These authors recorded auditory startle responses 
(ASRs) from masseter, orbicularis oculi, sternocleidomastoid, 
6Valls-Sole and Defazio Update on Blepharospasm
Frontiers in Neurology | www.frontiersin.org March 2016 | Volume 7 | Article 45
ReFeReNCeS
1. Marsden CD. The problem of adult-onset idiopathic torsion dystonia and 
other isolated dyskinesias in adult life (including blepharospasm, oroman-
dibular dystonia, dystonic writer’s cramp, and torticollis, or axial dystonia). 
Adv Neurol (1976) 14:259–76. 
2. Marsden CD. Blepharospasm-oromandibular dystonia syndrome (Brueghel’s 
syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg 
Psychiatry (1976) 39:1204–9. doi:10.1136/jnnp.39.12.1204 
3. Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology 
of primary dystonia. Lancet Neurol (2004) 3:673–8. doi:10.1016/
S1474-4422(04)00907-X 
and biceps brachii muscles and found abnormalities of different 
types (shortening latency, increased response probability, or 
enhanced response size in various of these muscles), pointing 
out to a general increase of response excitability to the auditory 
stimuli.
Patients with BSP have shown increased levels of activity in the 
orbicularis oculi in comparison to healthy subjects (66). One of 
the reasons for such increase in activity may be the visual stimuli 
acting on reflex contraction. Light is undoubtedly a source of dis-
comfort in patients with BSP and, consequently, reduced eyelid 
contraction force has been reported together with increased com-
fort and reduction of overall light sensitivity and BSP frequency 
in patients with BSP using FL-41 tinted lenses (67).
HYPOTHeSeS FOR FUTURe wORK
Many lines of research are of interest for further understanding 
the pathophysiological mechanisms of BSP. Various of them have 
been suggested along the previous paragraphs. In neuroimaging, 
it is apparent the shift of interest, driven out of building hypoth-
esis on experience, from early sites of secondary dystonias in the 
basal ganglia through the involvement of the parietal cortex and 
the thalamus to the most recent hint on the cerebellar dysfunc-
tion. Certainly, all these structures may form a network that is 
dysfunctional in BSP, but the exact contribution of each and 
the overall cause of the dysfunction are still unknown. Tools to 
study cerebellar function in relation to the eyelid movements or 
orbicularis oculi contraction are very scarce. Recently, though, 
Ryan and coworkers (68) have suggested that eyelid conditioning 
and long-term depression of the blink reflex induced by a high 
frequency electrical discharge on the trigeminal nerve before 
elicitation of the blink reflex may share the same circuits and 
suggested that such high frequency stimulation may be a way 
to long-term depress trigeminal blink circuit activity in diseases 
like BSP. In fact, studies of eyeblink conditioning in BSP have not 
been reported so far, probably because of the difficulties related 
to interference by involuntary spasms.
An area deserving more study in BSP is the relationship 
between the antagonistic muscles in control of eyelid position. 
The orbicularis oculi muscle is easily accessible with surface EMG 
but the levator palpebrae muscle requires needle recording and 
the recording system itself is nowadays undoubtedly interfering 
with normal behavior. Eyelid position is controlled involuntarily 
by many sources, including the amount of light, tiredness, emo-
tion, pain, and many other inputs. Likely, the levator palpebrae is 
tonically active most of the time, requiring some phasic contribu-
tion from the orbicularis oculi to refresh or reset the activity. A 
premovement silence of the tonic activity of the levator palpebrae 
may be needed for this muscle to have a burst of activity large 
enough to elevate the eyelid. The orbicularis oculi spasms may 
just be the result of unsuccessful attempts to reset the levator 
palpebrae, much as it has been described for the soleus when a 
standing person prepares for fast tip-toeing in a reaction time ask 
paradigm (69). How these mechanisms apply to BP is not yet fully 
understood but the fairly intimate relationship between the two 
muscles is certainly impaired in these patients.
Finally, another area in which research must be much reward-
ing for the care of BSP patients is the understanding of the role 
of eye diseases in the generation of BSP. A significant positive 
association between BSP and prior eye diseases has been reported 
by Defazio et al. (70). Symptoms of dry eye and other alterations 
are common in these patients but we do not know if they are 
consequent to, causative of, or concomitant with, BSP. Noxious 
stimuli may trigger reactions that are out of our conscious control. 
Awareness of them is not always easy and sensitization of circuits 
may take place even before the patient realizes that something is 
wrong. If we accept that this is one mechanism for the generation 
of BSP, we need early detection of possible eye disorders causing 
abnormal sensation or involuntary reactions to look for means to 
avoid consolidation of potentially abnormal circuits in case the 
disorder does not have a solution.
CONCLUSiON
There is much work to do to understand and treat BSP, ranging 
from muscle dysfunction to cerebral abnormalities. We do not 
know if some signs observed are cause or consequence of the 
disorder. The involuntary reaction of the body to a relatively 
small insult may modify circuits that later would lead to the 
complexity of symptoms characteristic of the disorder. We have 
to recognize the noxious stimulus that first triggered the process 
and separate it from the complex reactions leading to adaptation 
and compensation that finally lead to dystonia. The study of 
phenomenology can quantify and document the clinical expres-
sion of the disorder but this is not sufficient. Serious cooperation 
among various specialties is a must for the ophthalmologists to 
treat eye disorders, neurologists to detect early signs of abnormal 
behavior, psychologists to take care of emotional and cognitive 
disorders, rehabilitation experts to help generate beneficial plastic 
changes, and others.
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